» Articles » PMID: 29761110

Granulomatous Invasive Infection Involving the Nasal Sinuses and Brain

Overview
Specialty General Medicine
Date 2018 May 16
PMID 29761110
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Invasive fungal infections are commonly associated with some form of immunosuppression. On the nasal epithelial surface, , under favorable conditions, can aggressively breach multiple cell lines invading the local tissues. We present the case of a 35-year-old woman with granulomatous invasive infection involving the nasal sinuses and the brain. Antifungal agents administered in the previous episodes contained the infection; however, the infected site evolved over time surrounded with calcified tissues in the left maxillary sinus. The current infection involved the other side of the maxillary sinus and extended to the orbital cavity eroding the parts of the skull and retro-orbital structures and was treated with a long course of isavuconazole therapy.

Citing Articles

Systematic Review of Granulomatous Invasive Fungal Sinusitis Management.

Baqays A, Almutawa S, Alsabti R, Alsughayer L, Campbell S, Almaflehi N Laryngoscope Investig Otolaryngol. 2025; 10(1):e70086.

PMID: 39866555 PMC: 11761710. DOI: 10.1002/lio2.70086.


Mycoviruses in Fungi: Carcinogenesis of Fungal Agents May Not Always Be Mycotoxin Related.

Tebbi C J Fungi (Basel). 2023; 9(3).

PMID: 36983536 PMC: 10052198. DOI: 10.3390/jof9030368.


"Chronic granulomatous invasive fungal rhinosinusitis associated with SARS-CoV-2 infection: A case report".

Trevino-Gonzalez J, Santos-Santillana K, Maldonado-Chapa F, Morales-Del Angel J, Gomez-Castillo P, Cortes-Ponce J Ann Med Surg (Lond). 2021; 72:103129.

PMID: 34873446 PMC: 8636311. DOI: 10.1016/j.amsu.2021.103129.


Isavuconazole-Animal Data and Clinical Data.

Pagano L, Cattaneo C, Quattrone M, Oberti M, Mazzitelli M, Trecarichi E J Fungi (Basel). 2020; 6(4).

PMID: 33036295 PMC: 7712195. DOI: 10.3390/jof6040209.


It's all in your head: antifungal immunity in the brain.

Snarr B, Drummond R, Lionakis M Curr Opin Microbiol. 2020; 58:41-46.

PMID: 32828989 PMC: 7438209. DOI: 10.1016/j.mib.2020.07.011.


References
1.
Underhill D, Iliev I . The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol. 2014; 14(6):405-16. PMC: 4332855. DOI: 10.1038/nri3684. View

2.
Mellon J, Cotty P, Dowd M . Aspergillus flavus hydrolases: their roles in pathogenesis and substrate utilization. Appl Microbiol Biotechnol. 2007; 77(3):497-504. DOI: 10.1007/s00253-007-1201-8. View

3.
Mikulska M, Raiola A, Bruno B, Furfaro E, Van Lint M, Bregante S . Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant. 2009; 44(6):361-70. DOI: 10.1038/bmt.2009.39. View

4.
Lee R, Workman A, Carey R, Chen B, Rosen P, Doghramji L . Fungal Aflatoxins Reduce Respiratory Mucosal Ciliary Function. Sci Rep. 2016; 6:33221. PMC: 5021939. DOI: 10.1038/srep33221. View

5.
Behnsen J, Hartmann A, Schmaler J, Gehrke A, Brakhage A, Zipfel P . The opportunistic human pathogenic fungus Aspergillus fumigatus evades the host complement system. Infect Immun. 2007; 76(2):820-7. PMC: 2223477. DOI: 10.1128/IAI.01037-07. View